|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Number of the document | 1296984 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01938263.9 |
| Date of filing the European patent application | 2001-06-13 | |
| (97) | Date of publication of the European application | 2003-04-02 |
| (45) | Date of publication and mention of the grant of the patent | 2005-05-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2001/006747 |
| Date | 2001-06-13 |
| (87) | Number | WO 2001/098302 |
| Date | 2001-12-27 |
| (30) | Number | Date | Country code |
| 00202181 | 2000-06-22 | EP |
| (72) |
VENET, Marc, Gaston Janssen-Cilag S.A., FR
ANGIBAUD, Patrick, René Janssen-Cilag S.A., FR
END, David, William Janssen Pharmaceutica Inc., US
|
| (73) |
JANSSEN PHARMACEUTICA N.V.,
Patent Department Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING A FARNESYL TRANSFERASE INHIBITING 1,2-ANNELATED QUINOLINE ENANTIOMER |
| PHARMACEUTICAL COMPOSITION COMPRISING A FARNESYL TRANSFERASE INHIBITING 1,2-ANNELATED QUINOLINE ENANTIOMER |